Future ReGen Factor Treatments
The Longevity Industry will be the Biggest and Most Complex Industry in Human History and The Longevity industry will dwarf all other industries in both size and market capitalization.
Regenerative medicine has the potential to heal or replace tissues and organs damaged by age, disease, or trauma, as well as to normalize congenital defects. Promising preclinical and clinical data to date support the possibility for treating both chronic diseases and acute insults, and for regenerative medicine to abet maladies occurring across a wide array of organ systems and contexts, including dermal wounds, cardiovascular diseases and traumas, treatments for certain types of cancer, and more (1⇓–3). The current therapy of transplantation of intact organs and tissues to treat organ and tissue failures and loss suffers from limited donor supply and often severe immune complications, but these obstacles may potentially be bypassed through the use of regenerative medicine strategies. - Engineering growth factors for regenerative medicine applications - Angelo S. Mao and David J. MooneyPNAS November 24, 2015